X

Biotechnology

Cigna Group (CI) reports double-digit revenue growth for Q1; guides FY24

The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, Thursday reported a sharp increase in…

Infographic: A snapshot of Moderna’s (MRNA) Q1 2024 earnings results

Moderna, Inc. (NASDAQ: MRNA) reported a net loss for the first quarter of 2024 when the biotechnology company's revenues declined…

MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of…

BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite…

Key highlights from Abbott Laboratories (ABT) Q1 2024 earnings results

Abbott Laboratories (NYSE: ABT) reported its first quarter 2024 earnings results today. Total sales increased 2.2% year-over-year to $10 billion. Organic…

Femasys is committed to providing women with revolutionary healthcare products: CEO

Femasys Inc. (NASDAQ: FEMY) is a healthcare company that develops women's reproductive health solutions using state-of-the-art technology. The company’s portfolio…

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the…

Infographic: Highlights of Moderna’s (MRNA) Q4 2023 earnings results

Biotechnology company Moderna, Inc. (NASDAQ: MRNA) reported a sharp decline in revenues and earnings for the fourth quarter of 2023.…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers and institutions to accelerate the development…

BIIB Earnings: Here’s everything you need to know about Biogen’s Q4 report

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the fourth quarter of…

Earnings: Highlights of Eli Lilly & Company’s (LLY) Q4 2023 results

Eli Lilly and Company (NYSE: LLY) on Tuesday reported double-digit growth in revenues and adjusted earnings for the fourth quarter…

ABBV Earnings: Everything you need to know about AbbVie’s Q4 report

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced fourth-quarter 2023 financial results, reporting lower revenues and net income. The…

Eli Lilly and Company all set to report Q4 results. Here’s what to expect

Pharmaceutical company Eli Lilly and Company (NYSE: LLY) is preparing to report fourth-quarter earnings. In recent years, the drugmaker successfully…

MRK Earnings: Highlights of Merck’s Q4 2023 financial results

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp fall in adjusted earnings for the fourth quarter of…

Infographic: Highlights of Abbott Laboratories’ (ABT) Q4 2023 earnings report

Abbott Laboratories (NYSE: ABT), a diversified healthcare services company, Wednesday reported its fourth quarter 2023 financial results. Net income, excluding special…

Walgreens Boots Alliance (WBA) Q1 2024 profit and sales beat estimates

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the first quarter of 2024. Net…

Ocean Biomedical’s breast cancer research uncovers new tumor suppression pathway for its proprietary antibody

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said that new findings, co-authored by the company’s scientific co-founder Jack…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company focused on transforming biomedical inventions into cutting-edge therapies. The company develops…

Ocean Biomedical’s JV partner Virion presents positive oncology data at SITC 2023

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that works to accelerate the development and commercialization of discoveries from research…

Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As…

Earnings Summary: Highlights of Charles River Laboratories’ Q3 2023 results

Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023.…